Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets

Clinical trial NCT06214130 · COMPLETED

Trial details

NCT number: NCT06214130
Sponsor: Desitin Arzneimittel GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Drug Use

Start date: 2023-09-22
Primary completion: 2023-11-06
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.